360head Stockiq
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Moderna Inc (MRNA)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· US· www.modernatx.com
Trade MRNA on Webull →
15/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)47%

Also measured against its sector ETF (XBI).

Our last 30 days of resolved calls came true 18% of the time.See the track record →

Price
$223.37
1 day
-3.45%
1 week
-8.99%
1 month
-5.55%
1 year
+766.15%
Market cap
$90.4B
Company fundamentals
EPS (TTM)
$-7.10
Debt / Equity
0.52
Current ratio
3.62
Operating margin
-116.0%
Net margin
-110.5%
Gross margin
39.0%
Return on equity
-37.6%
Revenue growth (YoY)
13.1%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$218.59–$228.15
Stop-loss (exit)
$185.10 −17.1%
Target (exit)
$299.91 +34.3%

Volatility-scaled: the stop sits about 2× the average daily range (ATR 8.6% of price) below the price, with a 2:1 reward-to-risk target. Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 The dominant catalyst is product-related, driven by positive clinical/publication data for mNEXSPIKE and optimism around Moderna's personalized cancer vaccine pipeline. Continuation likelihood over the next few weeks is moderate (roughly 40–50%), as pipeline enthusiasm can fade without hard revenue or trial milestones to sustain momentum. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.

MRNA Signal Score & analysis · 360head Stockiq